Telangana Sets Its Sights on Global Life Sciences Leadership
The Government of Telangana has unveiled an ambitious policy framework aimed at establishing itself as one of the world's leading life sciences hubs by 2030. This initiative comes with strategic goals including attracting USD 25 billion in investments and creating over 500,000 high-quality jobs in the sector.
A Transformative Approach to Life Sciences
The Next-Gen Life Sciences Policy 2026–30 marks a significant shift from traditional large-scale manufacturing practices to an emphasis on innovation and high-value research. This shift will enable Telangana to integrate deeply into global life sciences value chains while enhancing the overall quality and impact of its contributions to healthcare and therapeutics.
Encouraging Innovation and Global Collaboration
Telangana's life sciences ecosystem is witnessing the establishment and expansion of several key global companies. Notable names include Amgen, Sanofi, and Bristol Myers Squibb, which have chosen Telangana for their research and development (R&D) operations. This trend reflects the growing confidence in the region's talent pool and its state-of-the-art infrastructure that supports biotechnology and life sciences initiatives.
High Ambitions for the Future
The policy aims to position Telangana among the top five life sciences clusters globally by 2030. By prioritizing value-led growth and innovation, the state is not just aiming to be a part of global supply chains but is also set to emerge as a source of cutting-edge therapies.
Key Components of the Policy
Significant elements of the Next-Gen Life Sciences Policy include the development of high-value R&D activities, advancement in therapeutics, and enhanced collaboration within the global market. The policy was launched at a high-profile event at the World Economic Forum, underscoring its intended global impact.
Chief Minister Mr. A. Revanth Reddy articulated commitment towards creating a robust biosciences ecosystem that resonates with international standards while serving broader global health needs. In support, the Minister for IT and Industries, Mr. D. Sridhar Babu, emphasized the role of the state as a leader in emerging fields like cell and gene therapies and precision fermentation.
Infrastructure Development and Financial Support
The policy implementation will also focus on building globally benchmarked infrastructure. Projects such as Green Pharma City, multiple Pharma Villages, and expansions of established zones like Genome Valley and the Medical Devices Park are central to this vision. These initiatives are designed to provide a powerful platform for innovation and growth in the life sciences sector.
Additionally, a dedicated Life Sciences Innovation Fund of up to INR 1,000 crore (USD 100 million) will support emerging and growth-stage companies. This fund is expected to drive investment in deep-tech ventures and stimulate private and institutional involvement in the life sciences sector. The establishment of the Telangana School of Life Sciences will further enhance educational resources, preparing future innovators and leaders in the field.
About Telangana Life Sciences
Telangana's trajectory over the past two decades has seen it transform from a manufacturing-oriented state into a multifaceted life sciences hub. Currently, the state is home to more than 2,000 life sciences companies and boasts numerous USFDA-approved manufacturing units, contributing significantly to the global vaccine supply. This evolution highlights Telangana's potential to be a cornerstone in supporting global healthcare supply chains.
In conclusion, Telangana’s Next-Gen Life Sciences Policy 2026–30 is a bold step towards establishing itself as a leading player in the global life sciences arena. With its proactive approach and commitment to innovation, the state is well-positioned to make strides in improving healthcare outcomes not just locally, but globally.
Frequently Asked Questions
What are the main goals of Telangana's Next-Gen Life Sciences Policy?
The policy aims to position Telangana among the global leaders in life sciences by targeting USD 25 billion in investments and creating over 500,000 jobs.
How will the policy change current manufacturing practices?
The policy shifts the focus from scale-driven manufacturing to innovation-driven and value-led growth in the life sciences sector.
Which notable companies are expanding in Telangana?
Companies like Amgen, Sanofi, and Bristol Myers Squibb have established R&D centers in Telangana, reflecting confidence in the local ecosystem.
What supports are being provided to startups under this policy?
A dedicated Life Sciences Innovation Fund up to INR 1,000 crore (USD 100 million) will catalyze early-stage innovations and attract investment in deep-tech ventures.
What infrastructure developments are planned?
Key developments include the Green Pharma City, multiple Pharma Villages, and expansions of Genome Valley to enhance the state's life sciences capabilities.
